Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s a
Go back to Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery™, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer’s a| Arbios Systems, Inc. (NASDAQ: ABOS) | Delayed: 2.59 -0.08 (3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.67 | 52 Week High | $0.23 | |||
| Open | $2.65 | 52 Week Low | $0.00 | |||
| Day High | $2.70 | P/E | N/A | |||
| Day Low | $2.50 | EPS | $0.00 | |||
| Volume | 300,209 | |||||
